Home > News > Certara acquisition regulatory writing

1 min read

Veristat Acquires Certara's Regulatory and Medical Writing Business

 

Veristat Expands Regulatory and Medical Writing Capabilities Through Acquisition of Certara’s Regulatory and Medical Writing Business

 

Veristat has completed the acquisition of the Regulatory and Medical Writing business from Certara, strengthening our ability to support sponsors across the full clinical development and regulatory submission lifecycle.


The acquisition significantly deepens our expertise in regulatory writing and submission strategy, adding more than 200 experienced professionals with a strong reputation for scientific rigor, operational excellence, and trusted client partnerships. Together, the combined organization expands Veristat’s ability to help sponsors navigate increasingly complex development programs and bring life-changing therapies to patients around the world, quickly and safely.


Over the past three decades, Veristat has built its reputation by helping sponsors solve some of the industry’s most complex clinical development, regulatory, and commercialization challenges. By uniting our complementary strengths and talented teams, Veristat and CRS together will have unmatched capabilities in biostats, medical writing, and regulatory affairs, made even stronger by our shared focus on science-based expertise, strong client partnerships, innovation, and impact. 


The acquisition reflects our continued commitment to building integrated, science-driven capabilities that help sponsors move programs forward with greater alignment, efficiency, and confidence from early development through regulatory submission and beyond.


We’re excited about the acquisition because it will deepen our regulatory writing and submission expertise and strengthen our overall position as a market leader uniquely positioned to support our clients in bringing life-changing medical therapies to patients everywhere, quickly and safely.


We also extend a warm welcome to the regulatory and medical writing teams joining Veristat. Their experience, scientific depth, and client-centered approach strengthen our culture and mission, while creating new opportunities to collaborate across disciplines in support of sponsors and patients worldwide.


For more information, please see Frequently Asked Questions at this link: https://www.veristat.com/certarar-rsmw-acquisition-2026-faq

2 min read

Meet Veristat at the ASCO Annual Meeting

May 5, 2026  Veristat Events

May 29 - June 2, 2026 | Chicago, IL

▶️ At the Forefront of Oncology Progress 

Veristat is pleased to attend the ASCO...

1 min read

Connect with Veristat at OCT East Coast

Apr 30, 2026  Veristat Events

May 12-13, 2026 – New Brunswick, NJ

⚛️ Where Clinical Operations Meet Real-World Execution

Veristat is pleased to...